ADC Therapeutics Announces Strategic Financial Restructuring with $86.6 Million Private Placement
ADC Therapeutics (ADCT) has announced a strategic financial restructuring that includes an $86.6 million private placement, aimed at extending the company's cash runway into 2029. The financing is structured as a private investment in public equity (“PIPE”) and comes from existing investors. This move reflects ADC Therapeutics' efforts to strengthen its balance sheet amid ongoing development of its oncology pipeline. By securing capital through familiar backers, the firm aims to reduce financial pressure while advancing clinical programs without diluting shareholder value significantly.
Tickers: $ADCT
Topics: PIPE financing private placement strategic restructuring